Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
Body-plethysmographic measurements of bronchodilator response in stable COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014
Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016
First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010
Pulmonary hyperinflation and postural balance in COPD patients Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016
Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016
Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Effect of pulmonary rehabilitation on cardiac function during exercise in COPD Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013
Effects of pulmonary rehabilitation on thoracoabdominal mechanic, dyspneia and daily activities in patients with COPD Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013
The use of capnometry for alveolar ventilation assessment in COPD patients Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014
Lung hyperinflation in COPD: the impact of pharmacotherapy Source: Eur Respir Rev 2006; 15: 85-89 Year: 2006
Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016
Influence of heart failure on resting inspiratory volumes in patients with COPD Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016
Comparison of exercise capacity, respiratory and peripheral muscle strength and dyspnea in patients with interstitial lung disease with and without chronotropic incompetence Source: International Congress 2015 – Physiotherapy outcomes and treatment in different patient profiles Year: 2015